# An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)

> **NCT02232698** · NA · COMPLETED · sponsor: **Abbott Diabetes Care** · enrollment: 328 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DEVICE:** Sensor Based Glucose Monitoring System
- **DEVICE:** Standard Blood Glucose Monitoring

## Key facts

- **NCT ID:** NCT02232698
- **Lead sponsor:** Abbott Diabetes Care
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 328 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02232698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02232698, "An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02232698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*